CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
1 stories
🇧🇷 G1 (PT)
National & Local

MG starts applying chikungunya vaccine developed by Instituto Butantan

Minas Gerais has begun administering a new chikungunya vaccine developed by Instituto Butantan, designed for adults aged 18 to 59 without immune deficiencies.

Feb 24 • 01:50 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.